COMPOUNDS MODULATING CANNABINOID CB1 RECEPTOR ACTIVITY, COMPOSITIONS BASED THEREON AND USE THEREOF

摘要

Compounds of formula (I) are modulators of cannabinoid receptor CB1. The invention also relates to pharmaceutical compositions comprising said compounds. The compounds of formula (I) can be used for manufacturing medicaments for the treatment of diseases or conditions which are mediated by CB1 receptor signaling activity, directly or indirectly associated with obesity and overweight; or an eating disorder, an addictive disorder, a mental disorder, a neurological disorders, sexual dysfunction, reproductive dysfunction, liver disease or fibrosis-related disease.